Dostmann W - Search Results

1

Structure and function of cGMP-dependent protein kinases.

Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, Hofmann F. Pfeifer A, et al. Among authors: dostmann w. Rev Physiol Biochem Pharmacol. 1999;135:105-49. doi: 10.1007/BFb0033671. Rev Physiol Biochem Pharmacol. 1999. PMID: 9932482 Review. No abstract available.

2

Identification of the amino acid sequences responsible for high affinity activation of cGMP kinase Ialpha.

Ruth P, Pfeifer A, Kamm S, Klatt P, Dostmann WR, Hofmann F. Ruth P, et al. Among authors: dostmann wr. J Biol Chem. 1997 Apr 18;272(16):10522-8. doi: 10.1074/jbc.272.16.10522. J Biol Chem. 1997. PMID: 9099696 Free article.

3

Structure and physiological role of cGMP-dependent protein kinase.

Hofmann F, Dostmann W, Keilbach A, Landgraf W, Ruth P. Hofmann F, et al. Among authors: dostmann w. Biochim Biophys Acta. 1992 Apr 30;1135(1):51-60. doi: 10.1016/0167-4889(92)90165-8. Biochim Biophys Acta. 1992. PMID: 1317212 Review. No abstract available.

4

Expression of a chimeric, cGMP-sensitive regulatory subunit of the cAMP-dependent protein kinase type I alpha.

Wild N, Herberg FW, Hofmann F, Dostmann WR. Wild N, et al. Among authors: dostmann wr. FEBS Lett. 1995 Nov 6;374(3):356-62. doi: 10.1016/0014-5793(95)01146-6. FEBS Lett. 1995. PMID: 7589570 Free article.

5

Determination of cyclic nucleotide-dependent protein kinase substrate specificity by the use of peptide libraries on cellulose paper.

Tegge W, Frank R, Hofmann F, Dostmann WR. Tegge W, et al. Among authors: dostmann wr. Biochemistry. 1995 Aug 22;34(33):10569-77. doi: 10.1021/bi00033a032. Biochemistry. 1995. PMID: 7654713

6

(D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha.

Nickl CK, Raidas SK, Zhao H, Sausbier M, Ruth P, Tegge W, Brayden JE, Dostmann WR. Nickl CK, et al. Among authors: dostmann wr. Biochim Biophys Acta. 2010 Mar;1804(3):524-32. doi: 10.1016/j.bbapap.2009.12.004. Epub 2009 Dec 16. Biochim Biophys Acta. 2010. PMID: 20018259 Free PMC article.

7

The catalytic domain of the cGMP-dependent protein kinase Ialpha modulates the cGMP-binding characteristics of its regulatory domain.

Dostmann WR, Koep N, Endres R. Dostmann WR, et al. FEBS Lett. 1996 Dec 2;398(2-3):206-10. doi: 10.1016/s0014-5793(96)01242-2. FEBS Lett. 1996. PMID: 8977108 Free article.

8

Ala335 is essential for high-affinity cAMP-binding of both sites A and B of cAMP-dependent protein kinase type I.

Zorn M, Fladmark KE, Ogreid D, Jastorff B, Døskeland SO, Dostmann WR. Zorn M, et al. Among authors: dostmann wr. FEBS Lett. 1995 Apr 10;362(3):291-4. doi: 10.1016/0014-5793(95)00261-7. FEBS Lett. 1995. PMID: 7729515 Free article.

9

(RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition.

Dostmann WR. Dostmann WR. FEBS Lett. 1995 Nov 20;375(3):231-4. doi: 10.1016/0014-5793(95)01201-o. FEBS Lett. 1995. PMID: 7498506 Free article.

10

Inhibition of cGMP-dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells.

Dey NB, Foley KF, Lincoln TM, Dostmann WR. Dey NB, et al. J Cardiovasc Pharmacol. 2005 May;45(5):404-13. doi: 10.1097/01.fjc.0000157455.38068.12. J Cardiovasc Pharmacol. 2005. PMID: 15821435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters